PROMINENT PSYCHIATRIC SYMPTOMS AND GLUCOSE HYPOMETABOLISM IN A FAMILY WITH A SNCA DUPLICATION
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The genomic duplication of the α-synuclein gene (SNCA) has been shown to cause familial parkinsonism.1,2 Although patients with SNCA duplication often exhibit similar features to those with idiopathic Parkinson disease (PD), we and others previously reported that patients with SNCA duplication may develop the phenotype of PD dementia (PDD).3,4 We identified a new family with SNCA duplication who developed parkinsonism, visual hallucination, and cognitive fluctuation, which are the characteristic phenotypes in patients with dementia with Lewy bodies (DLB). A PET study of this family revealed a pattern of cerebral glucose hypometabolism similarly described in patients with DLB.5
Case reports.
Patient 1.
The proband had symptoms of generalized anxiety disorder including palpitation, restlessness, sensation of dyspnea, and excessive worry 5 years prior to his first visit to our hospital with complaint of gait disturbance at age 47 years. On neurologic examination, poor facial expression, rigidity, and bradykinesia in his right extremities were noted. His cognitive function was apparently normal. At age 49, his bradykinesia has progressed and shuffling gait, impaired postural balance, and postural tremor were present. These symptoms were improved by treatment with l-dopa and cabergoline. At age 50, he developed visual hallucinations and delirium followed by obvious deficits in attention and verbal fluency, and prosopagnosia was occasionally noted. These psychiatric symptoms including his hallucinations were apparently unrelated to l-dopa therapy. He also exhibited fluctuating cognitive decline, as shown by his Mini-Mental State Examination (MMSE) score of 24 and Raven Colored Progressive Matrices score of 27.
Patient 2.
The mother of the proband …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Alert Me
Recommended articles
-
Articles
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodiesI.G. McKeith, C.G. Ballard, R.H. Perry et al.Neurology, March 14, 2000 -
Article
Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodiesTanis J. Ferman, Glenn E. Smith, Kejal Kantarci et al.Neurology, November 08, 2013 -
Article
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodiesDaniel Ferreira, Scott A. Przybelski, Timothy G. Lesnick et al.Neurology, September 28, 2020 -
Article
Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodiesHaruhiko Oda, Kazunari Ishii, Akira Terashima et al.Neurology, October 11, 2013